According to a recent study by SNS Insider, the global GLP-1 Receptor Agonist Market size valued at USD 60.6 billion in 2025, is anticipated to grow to USD 307 billion by 2035, registering a CAGR of 17.61% over the 20262035 forecast period. The increasing clinician acceptability of GLP-1 receptor agonists, the commercial success of blockbusters such as Ozempic and Wegovy, and new drug development are changing the face of diabetes and obesity treatment around the world
It reduces TNF-alpha production along with IL-1beta, IL-6, IL-8, and other cytokines at the transcriptional level
Other Ingredients: Hypromellose (vegetarian capsule), magnesium stearate (vegetable source), silicon dioxide
The idea of using a metric such as the clinically meaningful change can be applied to assess whether the outcome is not only statistically relevant, but would be meaningful to a person with a particular disease
Muscle pain is not listed among the most common tirzepatide reactions, but some patients report body aches, soreness, or weakness during treatment
